Breaking News
January 19, 2019 - FDA Approves Ontruzant (trastuzumab-dttb), a Biosimilar to Herceptin
January 19, 2019 - Tobacco use linked with higher use of opioids and sedatives
January 19, 2019 - Study delves deeper into developmental dyslexia
January 19, 2019 - Anti-vaccination movement one of the top health threats in 2019 says WHO
January 19, 2019 - Newly developed risk score more effective at identifying type 1 diabetes
January 19, 2019 - Highly effective protocol to prepare cannabis samples for THC/CBD analysis
January 19, 2019 - Prinston Pharmaceutical Inc. Issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodiethylamine (NDEA) in the Products
January 19, 2019 - How does solid stress from brain tumors cause neuronal loss, neurologic dysfunction?
January 19, 2019 - $14.7 million partnership to supercharge vaccine development
January 19, 2019 - Ian Fotheringham receives Charles Tennant Memorial Lecture award
January 19, 2019 - Brain vital signs detect neurophysiological impairments in players with concussions
January 19, 2019 - Lack of job and poor housing conditions increased likelihood of people attending A&E
January 19, 2019 - Novel targeted drug delivery system improves conventional cancer treatments
January 19, 2019 - Rutgers study finds gene responsible for spread of prostate cancer
January 19, 2019 - Complications Higher Than Expected for Invasive Lung Tests
January 19, 2019 - 3-D printed implant promotes nerve cell growth to treat spinal cord injury
January 19, 2019 - Automated texts lead to improved outcomes after total knee or hip replacement surgery
January 19, 2019 - Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study
January 19, 2019 - Drinking soft drinks while exercising in hot weather may increase risk of kidney disease
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
January 18, 2019 - Maintaining an active lifestyle in older age could prevent dementia
January 18, 2019 - New research detects mosquito known to transmit malaria for the first time in Ethiopia
January 18, 2019 - Researchers identify new genes linked to development of age-related macular degeneration
January 18, 2019 - Computerized method helps better protect pharma patents
January 18, 2019 - New guidelines to make swallowing safer for people in Australian nursing homes
January 18, 2019 - Lumex Instruments’ RA-915AM monitor installed at Hg treatment plant in Almadén, Spain
January 18, 2019 - ACCC survey finds multiple threats to growth of cancer programs
January 18, 2019 - Meeting the challenge of engaging men in HIV prevention and treatment
January 18, 2019 - Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
January 18, 2019 - Experts discuss various aspects on health risks posed by fumigated containers
January 18, 2019 - Researchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases
January 18, 2019 - Alpha neurofeedback training could be a means of enhancing learning success
January 18, 2019 - Innovative ‘light’ method demonstrates positive results in fight against malignant tumors
January 18, 2019 - The cytoskeleton of neurons found to play role in Alzheimer’s disease
January 18, 2019 - New resource-based approach to improve HIV care in low- and middle-income countries
January 18, 2019 - Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
First-of-its-kind study to test a personalized vaccine in cancer patient

First-of-its-kind study to test a personalized vaccine in cancer patient

image_pdfDownload PDFimage_print

Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.

Led by Stephen Schoenberger, PhD, professor of immunology at the La Jolla Institute for Allergy and Immunology (LJI), and Ezra Cohen, MD, professor of medicine at University of California San Diego School of Medicine, scientists and clinicians have developed a technology that reliably defines the neoantigens — foreign protein fragments recognized by the immune system — in a patient’s cancer.

With neoantigens identified, the team can identify peptides — strings of amino acids — that can be used to create a vaccine to stimulate a protective immune system response. Essentially, the information in a patient’s cancer is used to boost the immune system to initiate a stronger response from both cytotoxic and “helper” T cells — white blood cells that collaborate to destroy cancer cells.

“T cells need to recognize a cancer cell as being different before they can produce a response to destroy a patient’s tumor,” said Cohen, associate director for translational science at Moores Cancer Center and an internationally recognized physician-scientist who specializes in novel cancer therapies. “It’s a complicated process to harness this power into a vaccine. We are creating an incredibly personalized and precise therapy that is based on what that person’s cancer and immune system are telling us. Each vaccine we develop only applies to a specific individual.”

Tamara was selected as the first patient for the trial because, despite disease progression, her body remains strong, and is more likely to respond positively to the experimental immunotherapy treatment.

Tamara’s parents, Iris and Matthew Strauss, donated $1 million to help launch the clinical trial, hoping that a breakthrough treatment could help patients like their daughter beat their disease. The family has already lost one daughter to ovarian cancer.

After sequencing Tamara’s tumor and normal tissue, the team identified mutations expressed solely by cancer cells in her body. Schoenberger and LJI’s Bjoern Peters, PhD, developed a novel algorithm to select mutations that are recognized by the immune system. This algorithm was deployed to recognize the neoantigens that generated the strongest T cell response from Tamara’s tissue samples. These neoantigens were then presented to Tamara’s own T cells and cultured over a two-week period using 50 milliliters of her blood to develop a personalized vaccine.

“It’s been invention and new science every step of the way. This process simply hasn’t existed until we tried to build it here,” said Schoenberger. “By opening up our eyes and measuring what’s really happening with the cancer cells and the immune system, rather than predicting what we hope is there, we could make the transformational step needed to make this approach possible.”

Tamara’s vaccine took eight weeks to produce. When it was ready, Cohen took the vaccine filled syringe and administered it in Tamara’s upper arm, like a simple flu vaccine. After receiving the injection, Tamara said the liquid felt thick and warm, stinging just a bit more than a typical vaccine.

The vaccine is part of a one-two punch. In addition to the vaccine, patients receive pembrolizumab (Keytruda), a FDA-approved immune checkpoint blockade inhibitor that blocks abnormal interaction between the molecule PD-1 on immune cells and the molecule PD-L1 on cancer cells, allowing the immune cells to recognize and attack tumors. Combined with the vaccine, the drug should unleash the full potential of T cells activated by the vaccine, said Schoenberger.

During the trial, participants will return for two additional vaccine doses and remain on pembrolizumab for up to two years. Their health will be monitored for a minimum of five years.

“As much I would love to be cancer-free more than anything, I hope this vaccine truly does work because of the immense impact it could make on helping so many people, and easing the pain of what they go through as a cancer patient, would be phenomenal,” said Tamara.

The trial will enroll 10 participants with solid tumors whose disease has not responded to or has stopped responding to standard therapies. Cancer cells can adapt to treatment and become resistant, but inherent in the immune system is a way to prevent resistance, said Cohen. The idea is that the vaccine and check-point inhibitor will stimulate the immune response and that the vaccine will help the immune system to adapt with the cancer to prevent resistance from occurring.

“The first and foremost thing that I want is clinical benefit for these patients. I want their tumors to either stop growing or start shrinking,” said Schoenberger. “Scientifically, I want to be able to measure that the targets we’re identifying are relevant, that we see an increase in the number of T cells or in their functional capacity. That will let us know we’re really on to something. And then, I’m hoping that we can find the resources needed to treat more patients so we can be certain that this approach truly works.”

In addition to the philanthropic gift from the Strauss family, initial giving from the Immunotherapy Foundation created the infrastructure for the trial and funds raised by patient-advocates, Kristin and Wyatt Peabody helped launch the trial.

“Funding science that is this new, this innovative is challenging, but they recognize that this may be a paradigm shift for the way we treat cancer and the way we view cancer in the future,” said Cohen. “If we’re going to take the next big step toward curing cancer, we realized we have to do it on an individualized and personalized approach because that’s what cancer is. Every person’s cancer is different. We need to stop taking patients and try to fit them to drugs. We need to start making drugs and fitting them to what we’re seeing biologically in a patient’s cancer.”

Source:

https://ucsdnews.ucsd.edu/pressrelease/is_the_next_big_step_in_cancer_therapy_personalized_vaccines

Tagged with:

About author

Related Articles